Another case of Aspergillus niger mycetoma foot - Need to revisit causes of black grain eumycetomas
DOI:
https://doi.org/10.66344/jpad.30.4.2020.1504Keywords:
Aspergillus niger, eumycetoma, black grains, voriconazoleAbstract
We are reporting a case of eumycetoma caused by Aspergillus niger, which is the second ever case-report to the best of our knowledge and searchReferences
Angeline AK, Sangeetha MA. Mycetoma madura foot – case report. Int J Orthop Nurs. 2017;2(1):15-9.
Carter VH. On mycetoma or the fungus disease of India. London: J & A Churchill, 1874, p. 118.
Thompson HL. The present status of mycetoma. Arch Surg. 1928;16(3):774-88.
Fahal A, Mahgoub ES, Hassan AME, Abdel-Rahman ME. Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Negl Trop Dis. 2015; 9(3):e000-3679.
Pal M, Dave P. Mycetoma: an infectious neglected tropical devastating disease. CPQ Microbiol. 2019;3(3):01-09.
Mallick YA. Eumycetoma due to aspergillus niger: first case report and successful treatment with voriconazole. J Pak Assoc Dermatol. 2019;29(4):428-32.
Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol 2019; 44(2):123-9.
Dubey N, Capoor MR, Hasan AS, Gupta A, Ramesh V, Sharma S, et al. Epidemiological profile and spectrum of neglected tropical disease eumycetoma from Delhi, North India. Epidemiol Infect. 2019;147:e294.
Chander J. Subcutaneous mycosis mycetoma. In: A Textbook of Medical Mycology. 3rd ed. Mehta publishers; 2009:148–62.
Prasanna S, Grover N, Bhatt P, Sahni AK. A case of Aspergillus nidulans causing white granule mycetoma. Med J Armed Forces India. 2016;72(1):88–90.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.